The prospects of retinoids in the treatment of prostate cancer.
about
Oridonin induces G2/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells.Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.Sex specific retinoic acid signaling is required for the initiation of urogenital sinus bud development.PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiationAntagonizing Retinoic Acid Receptors Increases Myeloid Cell Production by Cultured Human Hematopoietic Stem Cells.Retinoic acid receptor modulators: a perspective on recent advances and promises.Gender specific issues in hereditary ocular disorders.An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium.Retinoid differentiation therapy for common types of acute myeloid leukemia.Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.Synthetic retinoids as potential antitumour agents
P2860
Q33598550-0E99FA5C-7373-4C70-B793-A624C4F39EB6Q33927817-86CA31D8-D7AB-41B6-B391-F4268C3798D1Q33989019-41B9A959-2D87-4C6B-82EB-57609CBAC994Q34414535-CE6A0773-41F1-4137-A45A-C156AD76AA09Q36890429-012FC97F-B568-487C-B8D6-AA0746B780E7Q37611247-B07A59D8-A560-4469-874D-4F2803BDE481Q37810949-80452D49-B917-4E6F-B3B8-59A24801AD2CQ38229062-021EE74B-C9DC-47B3-BD48-78C6D00AFEBAQ38800583-7999C1BB-B0EB-4FF9-8C18-B35FC3ED7F70Q41723841-A4A6ADEC-6792-4386-A9E2-E81A493CE78FQ42396664-472B2A7C-97CC-4289-9B91-1284D74C0574Q46459242-4D07D209-6C82-4A8B-B3BD-2768DE917152Q59081652-C8BBF242-9C9F-4A25-9E87-4A0685F9B971
P2860
The prospects of retinoids in the treatment of prostate cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The prospects of retinoids in the treatment of prostate cancer.
@ast
The prospects of retinoids in the treatment of prostate cancer.
@en
The prospects of retinoids in the treatment of prostate cancer.
@nl
type
label
The prospects of retinoids in the treatment of prostate cancer.
@ast
The prospects of retinoids in the treatment of prostate cancer.
@en
The prospects of retinoids in the treatment of prostate cancer.
@nl
prefLabel
The prospects of retinoids in the treatment of prostate cancer.
@ast
The prospects of retinoids in the treatment of prostate cancer.
@en
The prospects of retinoids in the treatment of prostate cancer.
@nl
P2093
P1433
P1476
The prospects of retinoids in the treatment of prostate cancer
@en
P2093
Jennifer Durham
Lisette A Hammond
Richard G Keedwell
Roshantha A S Chandraratna
P304
P356
10.1097/00001813-200209000-00001
P577
2002-09-01T00:00:00Z